Ahren Green
4Patents
2h-index
18Co-inventors
41Inventor score
Filing activity: Jul 21, 2003 → May 11, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7125865B2 | Therapeutic compounds for treating dyslipidemic conditions | Chemistry; Metallurgy | 19 | Expired |
| US8829196B2 | TRPA1 antagonists | Chemistry; Metallurgy | 2 | Active |
| US8030332B2 | Potassium channel inhibitors | Human Necessities | 0 | Active |
| US11786842B2 | Hybrid ligand and liquid chromatography stationary phase including hybrid ligand | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.